TH and Parkinson disease: In animal models of PD, Δ9-THCV, a CB2R agonist, reduced motor inhibition caused by 6-hydroxydopamine (6-OHDA) and the loss of TH–positive neurons caused by 6-OHDA lesion in the substantia nigra after an acute and chronic administrations, respectively.